Casio to Release Uterocervical Observation Camera in Taiwan

Tokyo, July 30, 2025 — Casio Computer Co., Ltd. announced today that it will release the DZ-C100 COLPOCAMERA, which is designed for uterocervical observation and photography in gynecological settings, and the CST-100M camera stand in Taiwan on July 30. To accompany them, the image management software D'z IMAGE Viewer C will also be available.

The DZ-C100 COLPOCAMERA, which supports the early detection of cervical cancer, and the CST-100M camera stand, designed for superior operability and convenience, have been approved as Class II medical devices by the Taiwan Food and Drug Administration (TFDA). These products will be launched on July 30 through Casio Taiwan Co., Ltd., a sales subsidiary.

The DZ-C100 has been highly praised for its ability to capture three high-definition image types (normal/green/polarized) with a single press of the shutter. Users also commend how the device allows them to focus on an area of observation just by touching it on the LCD monitor, among other features. Using the CST-100M stand simplifies moving and securing the camera in the preferred observation position, leading to more efficient photography. The capability to connect to a PC and utilize the D'z IMAGE Viewer C software for viewing and managing high-quality captured images has also earned significant applause.

Guided by the Casio Purpose — “Through the power to put wonder at hand, bring new levels of joy to lives one by one” — Casio delivers products and services that transform society. In its medical business, Casio has developed D'z IMAGE, an innovative diagnostic imaging system that applies the company’s unique image processing technology, which it has refined over many years. By providing medical cameras and cloud services under the D'z IMAGE brand, Casio assists medical professionals by enhancing operational efficiency for doctors in clinical settings and supporting early disease detection.

The DZ-C100 and CST-100M were initially launched in Japan in March 2022, followed by an international rollout that included Europe in September 2023, as well as the United States, Australia, and New Zealand in March 2024. With the new launch in Taiwan, Casio aims to further expand its medical business while continuing to contribute to global healthcare.

■ Available for purchase through the following Casio site:
https://www.casio.com/tw/medical-devices/products/gynecology/